S&P 500
(0.32%) 5 116.17 points
Dow Jones
(0.38%) 38 386 points
Nasdaq
(0.35%) 15 983 points
Oil
(-0.04%) $82.60
Gas
(1.82%) $2.07
Gold
(-0.65%) $2 342.40
Silver
(-1.46%) $27.26
Platinum
(-0.16%) $960.00
USD/EUR
(0.18%) $0.934
USD/NOK
(0.28%) $11.01
USD/GBP
(0.14%) $0.797
USD/RUB
(0.01%) $93.31

实时更新: Better Therapeutics, Inc. [BTTX]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间30 Apr 2024 @ 03:35

20.00% $ 0.0120

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 03:35):

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States...

Stats
今日成交量 238 785
平均成交量 5.88M
市值 654 187
EPS $0 ( 2024-04-04 )
下一个收益日期 ( $-0.120 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0100
ATR14 $0.00100 (8.33%)
Insider Trading
Date Person Action Amount type
2024-02-09 Perry David P Buy 839 895 Common Stock
2024-01-09 Perry David P Buy 1 471 453 Common Stock
2023-12-18 Perry David P Buy 3 750 Common Stock
2023-12-18 Carmona Richard H Buy 3 750 Common Stock
2023-12-18 Lavizzo-mourey Risa J Buy 3 750 Common Stock
INSIDER POWER
99.11
Last 98 transactions
Buy: 15 006 415 | Sell: 72 086

Better Therapeutics, Inc. 相关性

10 最正相关
FRBK0.881
EBC0.87
GSMG0.869
CSGP0.857
CBNK0.855
ADTN0.852
AADI0.852
CMLS0.85
DISH0.849
ACRS0.846
10 最负相关
TMKR-0.88
VRCA-0.878
BIOT-0.87
KSICU-0.866
SVSVU-0.865
HYAC-0.858
MSSA-0.853
RNLX-0.85
MHUA-0.85
NSIT-0.847

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Better Therapeutics, Inc. 财务报表

Annual 2022
营收: $0
毛利润: $-2.73M (0.00 %)
EPS: $-1.690
FY 2022
营收: $0
毛利润: $-2.73M (0.00 %)
EPS: $-1.690
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-1.709
FY 2020
营收: $8 000.00
毛利润: $-674 000 (-8 425.00 %)
EPS: $-0.334

Financial Reports:

No articles found.

Better Therapeutics, Inc.

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。